4.3 Article

Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris

期刊

IMMUNOBIOLOGY
卷 220, 期 10, 页码 1129-1135

出版社

ELSEVIER GMBH
DOI: 10.1016/j.imbio.2015.06.008

关键词

Pemphigus Vulgaris (PV); Th17/treg cells; Ror gamma t; Foxp3; Chemokine receptor-ligand (CCR6-CCL20 CCR4-CCL22)

资金

  1. Council of Scientific and Industrial Research (CSIR), New Delhi, INDIA

向作者/读者索取更多资源

Pemphigus Vulgaris (PV), a relatively common autoimmune blistering disease in India, primarily mediated by anti-Desmoglein 3 (anti-Dsg3) autoantibodies. T-helper 17 (Th17) and T-regulatory (Treg) cells play significant role in regulating immune homeostasis in autoimmune disorders. To understand immunopathogenesis of PV, it is crucial to unfold the phenotypic expression and functional characteristics of these cells along with their specific homing chemokine receptor-ligand. This proposed study aims to unravel the functional expression of Th17 and Treg cells along with their specific homing chemokine receptor-ligand, transcription factors and cytokine levels to better understand the immunopathogenesis of PV.The Flow cytometry results showed decreased frequency of Treg cells and high number of Th17 cells (p <0.001) indicating immune dysregulation in PV. A significant increase (p <0.001) in the serum levels of Th17 associated molecules (IL-17A, CCL-20) and relative expression of ROR gamma t, CCR6 and CCL20 was found in patients. For Treg cells, transcription factor FOXp3 was significantly lowered along with defective CCR4-CCL22 (p< 0.05) that might be playing an ambiguous role in Treg generated immune regulation, leading to homing defect at lesional sites. This maiden study revealed the role of defective receptor-ligand interface that might have failed to suppress inflammatory milieu produced by Th17 cells thus promoting inflammation and contributing to immunopathogenesis of PV. This chemokine receptor-ligand can further be explored as potential target for development of novel therapies in PV. (C) 2015 Elsevier GmbH. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据